ARGX · argenx SE
871.40
EURUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
Euro54.30B
PE
38.40
EV/EBITDA
48.3
DIV Yield
0%
Payout Ratio
0%
MQV Rating
1Very Strong
As at 18/09/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- HALO 100
- HALO 50
- HALO All
- HALO Balance Sheet
- HALO Capital Efficiency
- HALO Earnings Momentum
- HALO GARP
- HALO Momentum
- HALO MQV
- HALO MQV SMALL
- HALO Small
- Hammer Bullish
- Short Term Trend - Long
Key Fundamentals
EPS 3 yr Growth
-250.40%
EBITDA Margin
24.50%
Operating Cashflow
€751m
Free Cash Flow Return
12.90%
ROIC
19.70%
Interest Coverage
249.60
Quick Ratio
4.90
Performance
52 weeks range
Low 568.4 - 925
Trade Value (12mth)
US$19,711,633.00
1 week
1.43%
1 month
-1.94%
YTD
19.92%
1 year
39.55%
All time high
925.00
Additional Data
Shares Outstanding (Fully Diluted)
64m
HALO Sector
Healthcare
Next Company Report Date
04-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
EUR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Very Strong
Event
Neutral
Halo Model
Mqv
Very Strong
Garp
Very Strong
Mqv Small
Very Strong
Momentum
Price
Very Weak
Earnings
Very Strong
Growth
Earnings
Strong
Dividends
Very Weak
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Strong
Valuation
Value
Consensus
Yield
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Tim van Hauwermeiren | Individual |
| OrbiMed Advisors Private Equity | Subsidiary |
| Karen Massey | Individual |
| Karl Gubitz | Individual |
| Arjen Lemmen | Individual |
